Seroconversion after coronavirus disease 2019 vaccination in patients with immune deficiency.
作者信息
Squire Jacqueline, Joshi Avni
机构信息
Division of Pulmonary, Allergy, and Sleep Medicine, Department of Medicine, Mayo Clinic, Jacksonville, Florida.
Division of Allergic Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
出版信息
Ann Allergy Asthma Immunol. 2021 Sep;127(3):383-384. doi: 10.1016/j.anai.2021.05.015. Epub 2021 May 19.
Abstract
摘要
相似文献
1
Seroconversion after coronavirus disease 2019 vaccination in patients with immune deficiency.免疫缺陷患者接种2019冠状病毒病疫苗后的血清转化
Ann Allergy Asthma Immunol. 2021 Sep;127(3):383-384. doi: 10.1016/j.anai.2021.05.015. Epub 2021 May 19.
2
Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant.肾移植受者接种 3 剂 BNT162b2 mRNA SARS-CoV-2 疫苗后的细胞和体液免疫反应
Transplantation. 2021 Nov 1;105(11):e267-e269. doi: 10.1097/TP.0000000000003903.
3
Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients.抗CD20治疗的淋巴瘤患者接种新冠疫苗后的体液和细胞免疫反应
Blood. 2022 Jan 6;139(1):142-147. doi: 10.1182/blood.2021013445.
4
COVID-19 Vaccine Type and Humoral Immune Response in Patients Receiving Dialysis.接受透析患者的新冠疫苗类型与体液免疫反应
J Am Soc Nephrol. 2022 Jan;33(1):33-37. doi: 10.1681/ASN.2021070936. Epub 2021 Oct 13.
5
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.一剂自我转录和复制的基于 RNA 的 SARS-CoV-2 疫苗可在小鼠中产生保护性适应性免疫。
Mol Ther. 2021 Jun 2;29(6):1970-1983. doi: 10.1016/j.ymthe.2021.04.001. Epub 2021 Apr 5.
6
Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor T cell immunotherapy recipients.CD19靶向嵌合抗原受体T细胞免疫疗法接受者对三剂mRNA SARS-CoV-2疫苗的免疫反应。
Cancer Cell. 2022 Mar 14;40(3):236-237. doi: 10.1016/j.ccell.2022.01.010. Epub 2022 Jan 25.
7
Evaluation of the Immune Response Induced by CoronaVac 28-Day Schedule Vaccination in a Healthy Population Group.评估健康人群中按照 28 天程序接种科兴疫苗引起的免疫应答。
Front Immunol. 2022 Jan 31;12:766278. doi: 10.3389/fimmu.2021.766278. eCollection 2021.
8
T follicular helper cells in the humoral immune response to SARS-CoV-2 infection and vaccination.T 滤泡辅助细胞在 SARS-CoV-2 感染和疫苗接种的体液免疫反应中的作用。
J Leukoc Biol. 2022 Feb;111(2):355-365. doi: 10.1002/JLB.5MR0821-464R. Epub 2021 Nov 3.
9
Humoral and T-cell immune response following three doses of SARS-CoV-2 mRNA vaccine in giant cell arteritis: analysis of a prospective cohort.巨细胞动脉炎患者接种三剂严重急性呼吸综合征冠状病毒2（SARS-CoV-2）mRNA疫苗后的体液免疫和T细胞免疫反应：一项前瞻性队列分析
Clin Exp Rheumatol. 2024 Apr;42(4):942. doi: 10.55563/clinexprheumatol/mlatyf. Epub 2023 Sep 15.
10
Impact of Kidney Transplantation on Humoral Immunity Against SARS-CoV-2: A Case Series From Belgium.肾移植对针对严重急性呼吸综合征冠状病毒2的体液免疫的影响：来自比利时的病例系列
Transplantation. 2021 Nov 1;105(11):e257-e258. doi: 10.1097/TP.0000000000003910.
引用本文的文献
1
Adaptive Cellular Responses following SARS-CoV-2 Vaccination in Primary Antibody Deficiency Patients.原发性抗体缺陷患者接种SARS-CoV-2疫苗后的适应性细胞反应。
Pathogens. 2024 Jun 18;13(6):514. doi: 10.3390/pathogens13060514.
2
Clinical and immunological outcomes of SARS-CoV-2 infection in patients with inborn errors of immunity receiving different brands and doses of COVID-19 vaccines.先天性免疫缺陷患者接种不同品牌和剂量的 COVID-19 疫苗后对 SARS-CoV-2 感染的临床和免疫学结局。
Tuberk Toraks. 2023 Sep;71(3):236-249. doi: 10.5578/tt.20239705.
3
Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters.经 BNT162b2 加强针免疫后整合免疫参数识别出功能性 CVIDs 表型聚类。
Front Immunol. 2023 May 25;14:1194225. doi: 10.3389/fimmu.2023.1194225. eCollection 2023.
4
Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody Deficiencies.在以抗体缺陷为主的患者中，SARS-CoV-2 抗原刺激后的细胞因子反应。
Viruses. 2023 May 10;15(5):1146. doi: 10.3390/v15051146.
5
Detection of specific RBD IgG memory B cells by flow cytometry in healthcare workers and patients with inborn errors of immunity after BNT162b2 m RNA COVID-19 vaccination.通过流式细胞术检测 BNT162b2 mRNA COVID-19 疫苗接种后免疫缺陷患者和医护人员的 RBD 特异性 IgG 记忆 B 细胞。
Front Immunol. 2023 May 4;14:1136308. doi: 10.3389/fimmu.2023.1136308. eCollection 2023.
6
Long-Term Immunological Memory of SARS-CoV-2 Is Present in Patients with Primary Antibody Deficiencies for up to a Year after Vaccination.原发性抗体缺陷患者接种疫苗后长达一年仍存在新冠病毒的长期免疫记忆。
Vaccines (Basel). 2023 Feb 3;11(2):354. doi: 10.3390/vaccines11020354.
7
Infections in Inborn Errors of Immunity with Combined Immune Deficiency: A Review.先天性免疫缺陷合并免疫缺陷中的感染：综述
Pathogens. 2023 Feb 7;12(2):272. doi: 10.3390/pathogens12020272.
8
COVID-19 Severity, Cardiological Outcome, and Immunogenicity of mRNA Vaccine on Adult Patients With 22q11.2 DS.22q11.2DS 成年患者的 COVID-19 严重程度、心脏结局和 mRNA 疫苗的免疫原性。
J Allergy Clin Immunol Pract. 2023 Jan;11(1):292-305.e2. doi: 10.1016/j.jaip.2022.10.010. Epub 2022 Oct 21.
9
COVID-19-related health outcomes in people with primary immunodeficiency: A systematic review.原发性免疫缺陷患者的 COVID-19 相关健康结局：系统评价。
Clin Immunol. 2022 Oct;243:109097. doi: 10.1016/j.clim.2022.109097. Epub 2022 Aug 13.
10
Antibody response following the third and fourth SARS-CoV-2 vaccine dose in individuals with common variable immunodeficiency.在常见变异性免疫缺陷个体中，第三和第四剂 SARS-CoV-2 疫苗后的抗体反应。
Front Immunol. 2022 Jul 28;13:934476. doi: 10.3389/fimmu.2022.934476. eCollection 2022.
本文引用的文献
1
Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results.综述：接种 COVID-19 mRNA 疫苗的免疫后果：初步结果。
Front Immunol. 2021 Mar 12;12:657711. doi: 10.3389/fimmu.2021.657711. eCollection 2021.
2
Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center.一家医疗中心关于新冠病毒疫苗效果的早期证据。
N Engl J Med. 2021 May 20;384(20):1962-1963. doi: 10.1056/NEJMc2102153. Epub 2021 Mar 23.
3
Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer.针对 COVID-19 疫苗接种者和未接种者的严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）抗体：来自同一制造商的两种不同商业可用血清学检测方法的比较方法。
Clin Chim Acta. 2021 Jul;518:9-16. doi: 10.1016/j.cca.2021.03.007. Epub 2021 Mar 17.
4
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.mRNA 疫苗在实体器官移植受者中的单剂免疫原性。
JAMA. 2021 May 4;325(17):1784-1786. doi: 10.1001/jama.2021.4385.
5
Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products.健康供体血浆库和静脉注射免疫球蛋白产品中的抗SARS-CoV-2抗体。
Lancet Infect Dis. 2021 Jun;21(6):765-766. doi: 10.1016/S1473-3099(21)00059-1. Epub 2021 Feb 16.
6
Adaptive immunity to SARS-CoV-2 and COVID-19.对 SARS-CoV-2 和 COVID-19 的适应性免疫。
Cell. 2021 Feb 18;184(4):861-880. doi: 10.1016/j.cell.2021.01.007. Epub 2021 Jan 12.
7
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.医护人员中抗SARS-CoV-2抗体状态及感染发生率
N Engl J Med. 2021 Feb 11;384(6):533-540. doi: 10.1056/NEJMoa2034545. Epub 2020 Dec 23.
8
A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia.B细胞在新冠病毒疾病中可能发挥的作用？来自无丙种球蛋白血症患者的启示。
J Allergy Clin Immunol. 2020 Jul;146(1):211-213.e4. doi: 10.1016/j.jaci.2020.04.013. Epub 2020 Apr 22.
9
Vaccination in Primary Immunodeficiency Disorders.原发性免疫缺陷病的疫苗接种。
J Allergy Clin Immunol Pract. 2016 Nov-Dec;4(6):1066-1075. doi: 10.1016/j.jaip.2016.09.012.
Zotero 插件